Discover 585 paid clinical trials in Richmond, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 585
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
for
Type 2 Diabetes
Location: Midlothian VA, Burke VA, Canton OH, East Greenwich RI,
Sponsor: Housey Healthcare ULC
Sex: All
Age: 18+
Code: NCT07546929
Phase 2, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Midlothian VA, Charlottesville VA, Norfolk VA,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase 3, Recruiting
TERPS Trial for de Novo Oligometastic Prostate Cancer
for
Prostate Cancer, Oligometastatic Disease
Location: Midlothian VA, Glen Burnie MD, Columbia MD,
Sponsor: University of Maryland, Baltimore
Sex: Male
Age: 18+
Code: NCT05223803
Phase 2, Recruiting
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
for
Non-small Cell Lung Cancer
Location: Midlothian VA, Fredericksburg VA, Roanoke VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07190248
Phase 3, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Midlothian VA, Charlottesville VA, Norfolk VA,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
for
Breast Cancer
Location: Midlothian VA, New York NY, Westbury NY, Columbus OH,
Sponsor: Celcuity Inc
Sex: All
Age: 18+
Code: NCT06757634
Phase 3, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Midlothian VA, Norfolk VA, Baltimore MD, Roanoke VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase 3, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Midlothian VA, Charlottesville VA, Fairfax VA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase 3, Recruiting
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Midlothian VA, Fort Belvoir VA, Fairfax VA, Bethesda MD,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06350097
Phase 3, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Midlothian VA, Charlottesville VA, Norfolk VA,
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
for
Genetics of Drug Metabolism
Location: South Chesterfield VA, Arlington VA, Shippensburg PA,
Sponsor: Companion Dx Reference Lab, LLC
Sex: All
Age: 18+
Code: NCT02081872
Recruiting
CDR Investing in Fatherhood Process Study & Evaluation
for
Parenting, Parent-Child Relations
Location: Williamsburg VA
Sponsor: Child Development Resources
Sex: All
Age: 0+
Code: NCT03710135
Recruiting
New
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
for
Endometrial Neoplasms, Endometrial Cancer
Location: Williamsburg VA, Newport News VA, Suffolk VA,
Sponsor: Pfizer
Sex: Female
Age: 18+
Code: NCT07578649
Phase 3, Recruiting
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer (SCLC)
Location: Williamsburg VA, Newport News VA, Hampton VA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07226999
Phase 2, Phase 3, Recruiting
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
for
Non-cystic Fibrosis Bronchiectasis
Location: Williamsburg VA, Washington D.C. DC, Chapel Hill NC,
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Sex: All
Age: 18 - 70+
Code: NCT06559150
Phase 2, Recruiting
Shield Post-Approval Study Protocol
for
Colo-rectal Cancer
Location: Williamsburg VA, Chapel Hill NC, Hillsborough NC,
Sponsor: Guardant Health, Inc.
Sex: All
Age: 45 - 70+
Code: NCT06880055
Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Williamsburg VA, Charlottesville VA, Brandywine MD,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase 3, Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Williamsburg VA, Norfolk VA, Baltimore MD, New Bern NC,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT07082738
Phase 2, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Williamsburg VA, Potomac MD, Rosedale MD, Baltimore MD,